Literature DB >> 10593567

IDDM12 (CTLA4) on 2q33 and IDDM13 on 2q34 in genetic susceptibility to type 1 diabetes (insulin-dependent).

Z M Larsen1, O P Kristiansen, E Mato, J Johannesen, M Puig-Domingo, A de Leiva, J Nerup, F Pociot.   

Abstract

Type 1 diabetes (insulin-dependent) is a multifactorial disease with polygenic susceptibility. The major genetic component (IDDM1) resides within the HLA region, but several non-HLA loci have been implicated in the genetic susceptibility. In the present study, we have analysed two such loci, IDDM12 (CTLA4) on 2q33 and IDDM13 on 2q34, in Danish (n = 254) and Spanish (n = 39) type 1 diabetic multiplex families. No significant evidence of linkage of IDDM12 was observed in any of the two studied data sets. However, when the present data were combined with previously published data, they strengthened the evidence of linkage at this locus, p = 0.00002. For the IDDM13 region, we found some positive evidence of linkage of the D2S137-D2S164-D2S1471 markers (p-values 0.007, 0.02, and 0.007, respectively) using transmission disequilibrium testing (TDT) and the Tsp version of the TDT. Importantly, random transmission of all tested alleles was observed in unaffected offspring (p > 0.3). Stratification for HLA (high risk and non-high risk genotypes) in the Danish families did not reveal heterogeneity at IDDM12 or IDDM13. In conclusion, our data on an entirely new family data set did not support the existence of IDDM12 as a type 1 diabetes susceptibility locus in the Danish population. In addition, we found support for evidence of linkage and association of the IDDM13/D2S137-D2S1471 region (approximately 3.5 cM) to type 1 diabetes, however, further studies are needed to substantiate this observation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10593567     DOI: 10.3109/08916939908993857

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  10 in total

Review 1.  CTLA4 gene and autoimmune endocrinopathies: a new marker?

Authors:  F Pociot
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

2.  CTLA-4 gene polymorphism in promoter and exon-1 regions is not associated with Chinese patients with rheumatoid arthritis.

Authors:  Ming-Fei Liu; Chrong-Reen Wang; Pei-Chih Chen; Tsung-Liang Lin
Journal:  Clin Rheumatol       Date:  2004-01-28       Impact factor: 2.980

3.  A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: identification of new loci with evidence of interactions.

Authors:  J Nerup; F Pociot
Journal:  Am J Hum Genet       Date:  2001-10-11       Impact factor: 11.025

Review 4.  CTLA4 exon1 A49G polymorphism in Slovak patients with rheumatoid arthritis and Hashimoto thyroiditis-results and the review of the literature.

Authors:  Karim Benhatchi; Ivana Jochmanová; Viera Habalová; Hedviga Wagnerová; Ivica Lazúrová
Journal:  Clin Rheumatol       Date:  2011-04-19       Impact factor: 2.980

Review 5.  Molecular targeting of pancreatic disorders.

Authors:  Kiichi Tamada; Xiao-Ping Wang; F Charles Brunicardi
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

6.  CTLA4 is differentially associated with autoimmune diseases in the Dutch population.

Authors:  Alexandra Zhernakova; Peter Eerligh; Pilar Barrera; Joanna Z Wesoly; Joanna Z Weseloy; Tom W J Huizinga; Bart O Roep; Cisca Wijmenga; Bobby P C Koeleman
Journal:  Hum Genet       Date:  2005-07-16       Impact factor: 4.132

7.  The CTLA4 -819 C/T and +49 A/G dimorphisms are associated with Type 1 diabetes in Egyptian children.

Authors:  Hatem Mohamed Saleh; Nestor Rohowsky; Michael Leski
Journal:  Indian J Hum Genet       Date:  2008-09

8.  Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos.

Authors:  Teodorica L Bugawan; Daniel B Mirel; Ana M Valdes; Araceli Panelo; Paolo Pozzilli; Henry A Erlich
Journal:  Am J Hum Genet       Date:  2003-05-13       Impact factor: 11.025

9.  CTLA4 gene polymorphisms are associated with, and linked to, insulin-dependent diabetes mellitus in a Russian population.

Authors:  D A Chistiakov; K V Savost'anov; V V Nosikov
Journal:  BMC Genet       Date:  2001-03-27       Impact factor: 2.797

Review 10.  Risk factors and primary prevention trials for type 1 diabetes.

Authors:  Yan-Ling Wu; Yan-Ping Ding; Jian Gao; Yoshimasa Tanaka; Wen Zhang
Journal:  Int J Biol Sci       Date:  2013-07-18       Impact factor: 6.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.